✦ LIBER ✦

Three courses of high dose therapy. Feasibility in the treatment of multiple myeloma–a “France autogreffe” study

✍ Scribed by Philippe Colombat; Noel Milpied; Jean Philippe Laporte; Philippe Casassus; Claude Linassier; Jean Luc Harousseau

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 416 KB
Volume: 74
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19941201)74:11<2930::aid-cncr2820741107>3.0.co;2-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Toxicity of high-dose cytosine arabinosi

Toxicity of high-dose cytosine arabinoside in the treatment of advanced childhood tumors resistant to conventional therapy a pediatric oncology group study

✍ Cameron K. Tebbi; Jeffrey Krischer; Donald J. Fernbach; Donald H. Mahoney; Carlo 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB 👁 1 views

Feasibility and toxicity of high-dose th

Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: Survey from a single institution

✍ Massimo Magagnoli; Luca Castagna; Monica Balzarotti; Barbara Sarina; Inna Timofe 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 1 views

The addition of interferon or high dose

The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma : Phase III Eastern Cooperative Oncology Group clinical trial EST 9486

✍ Martin M. Oken; Traci Leong; Raymond E. Lenhard Jr.; Philip R. Greipp; Neil E. K 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

## BACKGROUND. Interferon (IFN) has demonstrated activity in the treatment of patients with multiple myeloma. A previous Eastern Cooperative Oncology Group (ECOG) study suggested that the rates of complete response (CR) and survival were increased with a regimen that alternated IFN with chemothera